The Central and Basolateral Amygdala Are Critical Sites of Neuropeptide Y/Y2 Receptor-Mediated Regulation of Anxiety and Depression

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 2.
Figure 2.

Expression of Cre recombinase in injected areas results in deletion of Y2 mRNA and a profound reduction in Y2 receptor binding. A, In situ hybridization showing expression of Cre mRNA in the BLA and CEA. Middle and bottom, Dark-field (middle) and bright-field (bottom) photomicrographs of photoemulsion-dipped sections showing Cre-positive cells (arrows) in the CEA. B, In situ hybridization showing Cre and Y2 mRNA expression and Y2 receptor binding in adjacent sections of the CEA in rAAV-Cre- and rAAV-GFP-injected Y2lox/lox mice (arrows mark injections sites). Note the significant reduction in Y2 mRNA levels as compared to the more modest loss of Y2 binding, as quantified in C. In contrast to changes in Y2 receptor mRNA, there was no change in concentrations of GABAA α2 subunit mRNA in the CEA 4 weeks after injection of rAAV-Cre into the CEA versus mice injected with rAAV-GFP (arrow heads), excluding an unspecific effect of Cre (B). Scale bars: A, 1 mm (film autoradiography), 50 μm (dark field), 10 μm (bright field); B, 500 μm. C, **p < 0.01, ***p < 0.001 as compared to all the respective controls (Student's t test).

  1. The Journal of Neuroscience vol. 30 no. 18 6282-6290
Responses to This Article
Be the first to respond to this article
Advertisement